111 related articles for article (PubMed ID: 7958470)
1. Expression of human immunodeficiency virus antigens in an attenuated Salmonella typhi vector vaccine.
Hone DM; Lewis GK; Beier M; Harris A; McDaniels T; Fouts TR
Dev Biol Stand; 1994; 82():159-62. PubMed ID: 7958470
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
3. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
4. Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine.
Fouts TR; Lewis GK; Hone DM
Vaccine; 1995 Apr; 13(6):561-9. PubMed ID: 7483777
[TBL] [Abstract][Full Text] [Related]
5. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
Gómez CE; Nájera JL; Jiménez EP; Jiménez V; Wagner R; Graf M; Frachette MJ; Liljeström P; Pantaleo G; Esteban M
Vaccine; 2007 Apr; 25(15):2863-85. PubMed ID: 17113200
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system.
Kotton CN; Lankowski AJ; Scott N; Sisul D; Chen LM; Raschke K; Borders G; Boaz M; Spentzou A; Galán JE; Hohmann EL
Vaccine; 2006 Sep; 24(37-39):6216-24. PubMed ID: 16824652
[TBL] [Abstract][Full Text] [Related]
7. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
AIDS Vaccine Evaluation Group 022 Protocol Team
J Infect Dis; 2001 Feb; 183(4):563-70. PubMed ID: 11170981
[TBL] [Abstract][Full Text] [Related]
8. Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120.
Fouts TR; Tuskan RG; Chada S; Hone DM; Lewis GK
Vaccine; 1995 Dec; 13(17):1697-705. PubMed ID: 8719522
[TBL] [Abstract][Full Text] [Related]
9. A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.
Evans TG; Keefer MC; Weinhold KJ; Wolff M; Montefiori D; Gorse GJ; Graham BS; McElrath MJ; Clements-Mann ML; Mulligan MJ; Fast P; Walker MC; Excler JL; Duliege AM; Tartaglia J
J Infect Dis; 1999 Aug; 180(2):290-8. PubMed ID: 10395842
[TBL] [Abstract][Full Text] [Related]
10. HIV gp120-specific cell-mediated immune responses in mice after oral immunization with recombinant Salmonella.
Berggren RE; Wunderlich A; Ziegler E; Schleicher M; Duke RC; Looney D; Fang FC
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):489-95. PubMed ID: 8548327
[TBL] [Abstract][Full Text] [Related]
11. Towards new mycobacterial vaccines.
Gicquel B
Dev Biol Stand; 1994; 82():171-8. PubMed ID: 7958472
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24.
Suzue K; Young RA
J Immunol; 1996 Jan; 156(2):873-9. PubMed ID: 8543845
[TBL] [Abstract][Full Text] [Related]
13. Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model.
Liu F; Mboudjeka I; Shen S; Chou TH; Wang S; Ross TM; Lu S
Vaccine; 2004 Apr; 22(13-14):1764-72. PubMed ID: 15068860
[TBL] [Abstract][Full Text] [Related]
14. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
[TBL] [Abstract][Full Text] [Related]
15. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.
Levine MM; Galen J; Barry E; Noriega F; Chatfield S; Sztein M; Dougan G; Tacket C
J Biotechnol; 1996 Jan; 44(1-3):193-6. PubMed ID: 8717403
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
17. A novel recombinant bacterial vaccine strain expressing dual viral antigens induces multiple immune responses to the Gag and gp120 proteins of HIV-1 in immunized mice.
Feng Y; Wang S; Luo F; Ruan Y; Kang L; Xiang X; Chao T; Peng G; Zhu C; Mu Y; Zhu Y; Zhang X; Wu J
Antiviral Res; 2008 Dec; 80(3):272-9. PubMed ID: 18639586
[TBL] [Abstract][Full Text] [Related]
18. A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes.
Lorin C; Delebecque F; Labrousse V; Da Silva L; Lemonnier F; Brahic M; Tangy F
Vaccine; 2005 Aug; 23(36):4463-72. PubMed ID: 15993518
[TBL] [Abstract][Full Text] [Related]
19. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
Shinoda K; Xin KQ; Kojima Y; Saha S; Okuda K; Okuda K
Clin Immunol; 2006 Apr; 119(1):32-7. PubMed ID: 16458074
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.
Belshe RB; Stevens C; Gorse GJ; Buchbinder S; Weinhold K; Sheppard H; Stablein D; Self S; McNamara J; Frey S; Flores J; Excler JL; Klein M; Habib RE; Duliege AM; Harro C; Corey L; Keefer M; Mulligan M; Wright P; Celum C; Judson F; Mayer K; McKirnan D; Marmor M; Woody G;
J Infect Dis; 2001 May; 183(9):1343-52. PubMed ID: 11294665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
